Associations of lower-body fat mass with favorable profile of lipoproteins and adipokines in healthy, slim women in early adulthood

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 5, 2011, Pages 365-372

  Tanaka, Sanae ^a   Bin, Wu ^a   Honda, Mari ^a   Suzuki, Kazuhisa ^a   Yoshino, Gen ^b   Fukuo, Keisuke ^a   Kazumi, Tsutomu ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Adiponectin; HDL; Lower body fat; Triglyceride; Trunk fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COLLEGE STUDENT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LIPID BLOOD LEVEL; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; WOMEN'S HEALTH;

ABSORPTIOMETRY, PHOTON; ADIPOKINES; ADIPOSE TISSUE; ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 79958047312     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.7229     Document Type: Article

References (45)

1. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE: Abdominal adiposity and coronary heart disease in women. JAMA, 1998; 280: 1843-1848
2. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, Barrett-Connor E: Association of total and central obesity with mortality in postmeno-pausal women with coronary heart disease. Am J Epidemiol, 2003; 158: 1161-1170
3. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of noninsulin-dependent diabetes mellitus in Women. The Nurses' Health Study. Am J Epidemiol, 1997; 145: 614-619
4. Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C: Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res, 2001; 9: 644-649
5. Heitmann BL, Frederiksen P, Lissner L: Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res, 2004; 12: 482-487
6. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehou-wer CD, Kostense PJ, Yudkin JS, Heine RJ, Nijpels G, Seidell JC: Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr, 2003; 77: 1192-1197
7. Seidell JC, Pérusse L, Deprés J-P, Bouchard C: Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk: the Quebec family study. Am J Clin Nutr, 2001; 74: 315-321
8. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE: Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab study. Int J Obes Relat Metab Disord, 2004; 28: 402-409
9. Aasen G, Fagertun H, Halse J: Regional fat mass by DXA: High leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women. Scan L Clin Lab Invest, 2008; 68: 204-211
10. Williams MJ, Hunter GR, Kekes-Szabo T, Snyder S, Treuth MS: Regional fat distribution in women and risk of cardiovascular disease. Am J Clin Nutr, 1997; 5: 855-860
11. van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM: Contribution of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab, 2002; 282: E1023-1028
12. van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM: Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab, 2005; 90: 4573-4578
13. Tatsukawa M, Kurokawa M, Tamari Y, Yoshimatsu H, Sakata T: Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenicity in Japanese. Proc Soc Exp Bio Med, 2000; 223: 156-162
14. Tank LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C: Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation, 2003; 107: 1626-1631
15. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehou-wer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC; Hoorn study: Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care, 2004; 27: 372-377
16. Snijder MB, Visser M, Dekker JM, Gooodpaster BH, Harris TB, Kritechevsky SB, De Rekeneire N, Kanaya AM, Newman AB, Tylavsky FA, Seidell JC; Health ABC Study: Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The health ABC study. Diabetologia, 2005; 48: 301-308
17. Snijder MB, Flyvbjerg A, Stehouwer CD, Frystyk J, Henry RM, Seidell JC, Heine RJ, Dekker JM: Relationship of adiposity with arterial stiffness as mediated by adi-ponectin in older men and women: the Hoorn Study. Eur J Endocrinol, 2009; 160: 387-395
18. Buemann B, Astrup A, Pedersen O, Black E, Holst C, Toubro S, Echwald S, Holst JJ, Rasmussen C, Sørensen TI; Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. J Clin Endocrinol Metab, 2006; 91; 1698-1704
19. Bentley-Lewis R, Koruda K, Seely EW: The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab, 2007; 3: 696-704
20. Boorsma W, Snijder MB, Nijpels G, Guidone C, Favuzzi AM, Mingrone G, Kostense PJ, Heine RJ, Dekker JM: Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity (Silver Spring), 2008; 16: 2696-2701
21. Matthews DR, Hosker J P, Rudenski AS, Naylor BA, Treacher D F, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabe-tologia, 1985; 28: 412-419
22. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 1999; 22: 1462-1470
23. Friedewald W T, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
24. Hirano T, Ito Y, Saegusa H, Yoshino G: A novel and simple method for quantification of small, dense LDL. J Lipid Res, 2003; 44: 2193-2201
25. Kobayashi J, Hashimoto H, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y, Yoshida S: Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta, 1993; 216: 113-123
26. Van Harmelen V, Dicker A, Ryden M, Hauner H, Lon-nqvist F, Naslund E, Arner P: Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes, 2000; 51: 2029-2036
27. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ: Differential regulation of adiponectin secretion from cultured human omen-tal and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Endocrinol Metab, 2002; 87: 5662-5667
28. Manolopoulos KN, Karpe F, Frayn KN: Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond), 2010; 34: 949-959
29. Marie-Christine Alessi, Delphine Bastelica, Alenka Mavri, Pierre Morange, Bruno Berthet, Michel Grino, Irene Juhan-Vague: Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol, 2003; 23: 1262-1268
30. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes, 1997; 46: 860-867
31. Messier V, Karelis AD, Robillard ME, Bellefeuille P, Bro-chu M, Lavoie JM, Rabasa-Lhoret R: Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism, 2010; 1: 20-24
32. Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Kra-koff J, Bunt JC: Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adi-pocyte enlargement, visceral adiposity, and hypoadiponec-tinemia in obese individuals. Am J Clin Nutr, 2008; 87: 295-302
33. Alina Gavrila, Jean L. Chan, Nikos Yiannakouris, Meropi Kontogianni, Lisa C. Miller, Christine Orlova, Christos S. Mantzoros: Serum Adiponectin Levels Are Inversely Associated with Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Inter-ventional Studies. J Clin Endocrinol Metab, 2003; 88: 4823-4831
34. Hanley AJ, Bowden D, Wagenknecht LE, Balasubraman-yam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM: Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab, 2007; 92: 2665-2671
35. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A: Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metab Disord, 2000; 24: 1392-1395
36. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1998; 83: 859-862
37. Perry CD, Alekel DL, Ritland LM, Bhupathiraju SN, Stewart JW, Hanson LN, Matvienko OA, Kohut ML, Reddy MB, Van Loan MD, Genschel U: Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause, 2008; 15: 619-627
38. Good M, Newell FM, Haupt LM, Whitehead J P, Hutley LJ, Prins JB: TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue--influence of BMI and adipose distribution. Diab Vasc Dis Res, 2006; 3: 26-33
39. Bos G, Snijder MB, Nijpels G, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, Jansen H: Opposite contributions of trunk and leg fat mass with plasma lipase activities: the Hoorn study. Obes Res, 2005; 13: 1817-1823
40. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr Opin Lipidol, 1995; 6: 291-305
41. Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K: Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias. Atherosclerosis, 1999; 145: 45-50
42. Pont F, Duvillard L, Florentin E, Gambert P, Vergès B: Early kinetic abnormalities of apoB-containing lipopro-teins in insulin-resistant women with abdominal obesity. Arterioscler Thromb Vasc Biol, 2002; 22: 1726-1732
43. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ: Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation, 2004; 109: 1918-1925
44. Walldius G, Jungner I: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med, 2006; 259: 493-519
45. Goodpaster BH, Thaete FL, Kelley DE: Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr, 2000; 71: 885-892